Results 191 to 200 of about 209,035 (336)

The FIB-4 Index Is Independently Associated with QTc Interval in Patients with Ankylosing Spondylitis. [PDF]

J Clin Med
Ergül E, Durak H, Çetin M, Duman H, Emlek N, Yılmaz AS, Özyıldız AG, Barutçu G, Cüre O.   +8 more
europepmc   +1 more source

Prolongation of renal allograft survival by anergic cells: advantages and limitations [PDF]

, 2010
Hisashi Bashuda, Akira Shimizu, Masateru Uchiyama, Ko Okumura   +3 more
openalex   +1 more source

Predicting drug‐induced QT prolongation and torsades de pointes

Journal of Physiology, 2016
D. Roden
semanticscholar   +1 more source

Network Localization of Fatigue in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Fatigue is among the most common symptoms and one of the main factors determining the quality of life in multiple sclerosis (MS). However, the neurobiological mechanisms underlying fatigue are not fully understood. Here we studied lesion locations and their connections in individuals with MS, aiming to identify brain networks ...
Olli Likitalo, Jaakko Kungshamn, Albert Bellmunt‐Gil, Silvia Tommasin, Abhineet Ojha, Matias Viitala, Juho Aaltonen, Jyrki Lötjönen, Juha Koikkalainen, Pauli Ylikotila, Patrizia Pantano, Merja Soilu‐Hänninen, Juho Joutsa   +12 more
wiley   +1 more source

Cardiac conduction abnormalities in myotonic dystrophy type I: The ongoing value of the ECG. [PDF]

Int J Cardiol Heart Vasc
Abumayyaleh M, Schupp T, Behnes M, Akin I.   +3 more
europepmc   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Hypoglycaemia and Cardiac Arrhythmias in Type 1 Diabetes Mellitus: A Mechanistic Review. [PDF]

J Pers Med
Mavromoustakou K, Fragoulis C, Cholidou K, Sotiropoulou Z, Anagnostopoulos N, Gastouniotis I, Lontou SP, Dimitriadis K, Thanopoulou A, Chrysohoou C, Tsioufis K.   +10 more
europepmc   +1 more source

A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongation

, 2014
Jay W. Mason, Thomas E. Moon, Erin O’Boyle, Albert G. H. Dietz   +3 more
openalex   +2 more sources

Erratum: Rigid body motions, space curves, prolongation structures, fiber bundles, and solitons [J. Math. Phys. 2 0, 1667(1979)] [PDF]

, 1980
M. Lakshmanan
openalex   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source